Filing status
- Accounts due
- 31 December 2026
- Last accounts
- 31 December 2024
- Conf. stmt due
- 27 March 2027
- Last conf. stmt
- 13 March 2026
Bluebird Bio (UK) Ltd.
- Incorporated
- 14 March 2016 (10 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Wendy Frances Mary Dicicco
- Owned by
- Genetix Biotherapeutics Inc.
- Accounts type
- Full
- Region
- Greater London
- Address
- 21 Holborn ViaductLondonEC1A 2DY
Officers 1 active
Officer details are public data from the Companies House register.
Dicicco, Wendy Frances Mary
Director · Appointed 7 November 2025
American
Born June 1967 (59)
Officer history (14 former)
17 November 2025
Resigned Klima, Thomas Joseph as Director
7 November 2025
Appointed Dicicco, Wendy Frances Mary as Director
15 May 2025
Appointed Klima, Thomas Joseph as Director
15 May 2025
Resigned Obenshain, Andrew Barbour as Director
8 October 2022
Resigned Cole, Jason F. as Secretary
8 October 2022
Resigned Cole, Jason F. as Director
7 October 2022
Appointed Obenshain, Andrew Barbour as Director
29 June 2022
Resigned Asinas, Deborah Lee as Director
20 October 2021
Resigned Danison, Douglas Edmund as Director
20 October 2021
Appointed Asinas, Deborah Lee as Director
20 October 2021
Resigned Heffron, Nicola Helen as Director
20 October 2021
20 October 2021
Resigned Matala, Erik as Director
14 June 2021
Appointed Danison, Douglas Edmund as Director
14 June 2021
Resigned Seeberger, David Henrik as Director
27 January 2020
Appointed Heffron, Nicola Helen as Director
27 January 2020
Resigned Obenshain, Andrew as Director
13 March 2019
Appointed Matala, Erik as Director
20 December 2018
25 June 2018
Appointed Seeberger, David Henrik as Director
25 June 2018
Resigned Walsh, Jeffrey Thomas as Director
4 August 2017
Appointed Walsh, Jeffrey Thomas as Director
4 August 2017
Resigned Sullivan, Eric Michael as Director
30 March 2017
Resigned Leschly, Nick as Director
30 March 2017
Appointed Obenshain, Andrew as Director
14 March 2016
Appointed Sullivan, Eric Michael as Director
14 March 2016
Appointed Cole, Jason F. as Secretary
14 March 2016
Appointed Leschly, Nick as Director
14 March 2016
Appointed Cole, Jason F. as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Genetix Biotherapeutics Inc.
Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Corporation
Reg. no. 2294895
Filings 64
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 14 April 2026 | Confirmation statement with updates | 13 March 2026 | ||
| 18 March 2026 | Change of details for a person with significant control | |||
| 27 February 2026 | Full accounts | 31 December 2024 | ||
| 23 December 2025 | Insolvency filing | |||
| 23 December 2025 | Share capital filing |
Some other companies at this address
Other companies in this industry
Sandwich
Newcastle Upon Tyne
Edinburgh
Edinburgh
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →